Nobivac Intra-Trac3 ADT

Nobivac® Intra-Trac®3 ADT Manufacturer:Merck Animal Health This treatment applies to Dogs. Canine Adenovirus Type 2-parainfluenza-bordetella Bronchiseptica Vaccine Modified Live Virus and Avirulent Live Culture (Advanced Delivery Technology) THIMEROSAL FREE For Intranasal Use In Dogs Only Product Description Nobivac® Intra-Trac® 3 ADT vaccine is recommended for use as an aid in the prevention of disease associated with canine adenovirus type 2, canine parainfluenza virus and Bordetella bronchiseptica infection in healthy dogs 3 weeks of age or older. These agents have been implicated as playing a role in the etiology of the condition known as canine kennel cough. A proven 1-year intranasal vaccine that provides triple protection against the agents implicated in the cause of tracheobronchitis (“canine cough”) with unique Advanced Delivery Technology (ADT). Features and benefits Protects against Bordetella, canine parainfluenza virus, and canine adenovirus type 2. ADT eliminates the possibility of accidental injection Offers the superior benefits of intranasal administration Can be used in puppies as young as 3 weeks of age because maternal antibodies do not interfere with localized antibody response Requires only single-nostril administration—low dose of 0.5 mL When To Vaccinate Vaccinate dogs intranasally at 3 weeks of age or older. Annual revaccination with one dose is recommended. Following the advice of the American Veterinary Medical Association on Vaccination Principles, an appropriate revaccination program for individual animals should be made based upon veterinarian-client-patient relationships. Preparation Of The Vaccine: Rehydrate with the accompanying sterile diluent. Shake well and draw back into the syringe the required amount. Remove the needle from the syringe and attach the enclosed applicator tip. Use immediately. Dosage and Administration: Instill 0.5 mL of rehydrated vaccine into each nostril using a syringe with applicator tip. Annual revaccination is recommended. The recommended dose is 0.5 mL of rehydrated vaccine administered intranasally. The vaccine is instilled using a nasal disk. By gently squeezing the body of the nasal applicator, squirt the rehydrated vaccine into one or both nostrils of the dog. Caution(s): 1. THIS PRODUCT IS DESIGNED FOR INTRANASAL USE ONLY WITH THE ENCLOSED DILUENT. Systemic reactions resulting from inadvertent intramuscular or subcutaneous injection have been reported. Symptoms may include vomiting, diarrhea, lethargy, inappetence, jaundice and death associated with liver failure. Localized tissue necrosis at the injection site has also been reported. If inadvertent injection occurs, monitor the dog closely. Supportive therapy including IV fluids and treatment with gentamicin, tetracycline, trimethoprim/sulfa, or amoxicillin/clavulanic acid may be indicated. If anaphylactoid reaction occurs, use epinephrine. 2. Post vaccinal reactions consisting of mild canine cough may occur following use of this vaccine. 3. For veterinary use only. Store at 2° - 7°C (35° - 45°F). Use entire contents when first opened. Burn all nasal applicators, vaccine vials and all unused contents. 4. This vaccine contains penicillin, streptomycin and nystatin as preservatives. For veterinary use in dogs only. FOR INTRANASAL USE ONLY. Intervet Inc., Omaha, Nebraska, 68103, USA 1 800 224-5318 (USA) U.S. Veterinary License No. 165A Presentation: 25 x 1 Dose. Nac No. 10472392 INTERVET INC., MERCK ANIMAL HEALTH 556 MORRIS AVE., SUMMIT, NJ, 07901 Telephone: 908-473-5552 Order Desk: 800-648-2118 Fax: 908-473-5560 Customer Service: 800-521-5767 This item is NON-RETURNABLE and NON-REFUNDABLE.